FDA Grants Emergency Use Authorization for Hologic's Aptima Zika Virus Assay
MARLBOROUGH, Mass., June 17, 2016 / / -- Hologic, Inc. read more
View ArticleFDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to...
Blood banks will use the new test, co-developed by Hologic and Grifols, to screen donated blood in potential endemic areas of the US. Test will run on the Procleix Panther System, a fully automated NAT...
View ArticleChildren and Adolescents to Receive Additional Tailored Mental Health...
ATLANTA…The Carter Center has partnered with the UBS Optimus Foundation to improve the well-being of vulnerable youth in Liberia by tailoring and strengthening the national mental health care system to...
View ArticleEmergency facilities a vital key to Ebola survival
Emergency health facilities could be the key to survival for Ebola patients, an international study involving University of Queensland researchers has found. read more
View ArticleEbola vaccine development: still more to be done
A panel of international experts has called for continued commitment to Ebola vaccine development to fully prepare for the next outbreak. read more
View ArticleU.S. FDA Grants Abbott the First Commercial Authorization for a Molecular...
ABBOTT PARK, Ill., Feb. 2, 2017 / / -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has authorized its molecular test, the Abbott RealTime ZIKA test, to detect...
View ArticleWHO Regional Director for Africa, Dr Matshidiso Moeti travels to Kinshasa to...
The WHO Regional Director for Africa, Dr. Matshidiso Moeti today visited Kinshasa (DR Congo) to discuss with national authorities and partners ways to mount a rapid, effective and coherent response in...
View ArticleGrifols Makes Procleix Zika Virus Assay Available for Screening Blood...
Barcelona, May 23, 2017 - Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), one of the world's leading producers of plasma-derived medicines, now provides European countries accepting products with the...
View ArticleScientists from SRI International and Collaborations Pharmaceuticals, Inc....
MENLO PARK, Calif.— December 7, 2017 — In the search for drugs that are effective against Ebola virus, scientists from SRI International and Collaborations Pharmaceuticals, Inc., led a study that used...
View ArticleEbola in Africa: U-M experts available to discuss
Ebola in the Democratic Republic of Congo has spread from rural Bikoro to Mbandaka, a city of 1.2 million on the Congo River, and health officials have begun distributing an experimental vaccine....
View ArticleNew measures and strong partnership having positive impact on Ebola response...
New measures to overcome challenges in the response to the Ebola outbreak in the Democratic Republic of the Congo (DRC) are having a positive impact, although the outbreak remains dangerous and...
View ArticleDemocratic Republic of the Congo begins first-ever multi-drug Ebola trial
The Ministry of Health of the Democratic Republic of the Congo (DRC) today announced that a randomized control trial has begun to evaluate the effectiveness and safety of drugs used in the treatment of...
View ArticleNC Public Health and Emergency Management Officials Conducting Ebola Drill
Officials from the North Carolina Department of Health and Human Services and the NC Department of Public Safety will be participating with federal, state and local officials in a multi-state Ebola...
View Article
